Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension
about
Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional considerationDysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaGroup 5 Pulmonary Hypertension: The Orphan's Orphan Disease.Pulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.Effect of acetylsalicylic acid on thalassemia with pulmonary arterial hypertensionPost splenectomy related pulmonary hypertension.Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.Treatment of pulmonary hypertension in three patients with ß-thalassemia intermedia using pulmonary arterial hypertension-specific medications.Pulmonary hypertension associated with thalassemia syndromes.Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine.Response to "efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up " Haematologica 2014;99(2):e17-18.Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up.Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?
P2860
Q26742061-FD51D76B-768C-4BCC-ABCD-91046A9EA52DQ28395387-40ED8F4D-3F4A-44E0-B23F-66180AB0495EQ30248872-9EB6BB99-E3B0-4696-8C2C-80AE777F6F9DQ33165207-892A44AC-B6B5-4086-86A9-8C936AB704C6Q33419337-A4592664-D3BE-41C4-8037-3643A923E128Q36653460-DC3D2D94-DB43-4B0D-B5E9-A112D44A4A29Q37565002-FD71BEDD-7FDC-4D2A-99BB-8BA6BBACA1CDQ37680252-EE2D2595-8D74-43B9-B33C-79E1D0CD1B88Q38786355-3C6FF06A-95C0-4B86-A1AD-2A440B626145Q39226887-5074C93C-DD0A-4BF8-B37E-8560244D5A26Q42632177-1AE34A1F-B2E4-47A5-BE6F-472EA8B26EC0Q42632211-DA872AB1-67F8-4208-A276-76D4AFF09BE7Q47799282-2D80C8F2-38CF-41F8-8796-3E8325A0B861Q50092007-DC35C4F4-A9E5-40D9-85BC-2E8932D5FBF5
P2860
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sildenafil therapy in thalasse ...... risk of pulmonary hypertension
@en
Sildenafil therapy in thalasse ...... isk of pulmonary hypertension.
@nl
type
label
Sildenafil therapy in thalasse ...... risk of pulmonary hypertension
@en
Sildenafil therapy in thalasse ...... isk of pulmonary hypertension.
@nl
prefLabel
Sildenafil therapy in thalasse ...... risk of pulmonary hypertension
@en
Sildenafil therapy in thalasse ...... isk of pulmonary hypertension.
@nl
P2093
P2860
P1433
P1476
Sildenafil therapy in thalasse ...... risk of pulmonary hypertension
@en
P2093
Alexis A Thompson
Claudia R Morris
Elizabeth S Klings
Ellis J Neufeld
Felicia L Trachtenberg
Frans A Kuypers
Hae-Young Kim
Janet L Kwiatkowski
John B Porter
P2860
P304
P356
10.3324/HAEMATOL.2012.082065
P577
2013-04-12T00:00:00Z